BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3489937)

  • 1. Stable integration of mouse DNA into Ia-negative human B-lymphoma cells causes reexpression of the human Ia-positive phenotype.
    Guardiola J; Scarpellino L; Carra G; Accolla RS
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7415-8. PubMed ID: 3489937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivation by a trans-acting factor of human major histocompatibility complex Ia gene expression in interspecies hybrids between an Ia-negative human B-cell variant and an Ia-positive mouse B-cell lymphoma.
    Accolla RS; Carra G; Guardiola J
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5145-9. PubMed ID: 3875096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct mechanisms regulate MHC class II gene expression in B cells and macrophages.
    Maffei A; Scarpellino L; Bernard M; Carra G; Jotterand-Bellomo M; Guardiola J; Accolla RS
    J Immunol; 1987 Aug; 139(3):942-8. PubMed ID: 3110290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans-acting element(s) operating across species barriers positively regulate expression of major histocompatibility complex class II genes.
    Accolla RS; Scarpellino L; Carra G; Guardiola J
    J Exp Med; 1985 Oct; 162(4):1117-33. PubMed ID: 3862745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells.
    Sartoris S; Tosi G; De Lerma Barbaro A; Cestari T; Accolla RS
    Eur J Immunol; 1996 Oct; 26(10):2456-60. PubMed ID: 8898960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules.
    De Lerma Barbaro A; Sartoris S; Tosi G; Nicolis M; Accolla RS
    J Immunol; 1994 Nov; 153(10):4530-8. PubMed ID: 7525708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of a DNA-protein complex correlates with extinguished major histocompatibility complex class II expression in a human B cell.
    Finn PW; Van TT; Accolla RS; Glimcher LH
    J Exp Med; 1990 Jun; 171(6):2159-64. PubMed ID: 2351936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression.
    Accolla RS; Jotterand-Bellomo M; Scarpellino L; Maffei A; Carra G; Guardiola J
    J Exp Med; 1986 Jul; 164(1):369-74. PubMed ID: 3088202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant human B cell lines deficient in class II major histocompatibility complex transcription.
    Calman AF; Peterlin BM
    J Immunol; 1987 Oct; 139(7):2489-95. PubMed ID: 3116083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic target of the Air-1 trans-activator revealed by stable transfection assay.
    Sartoris S; De Lerma Barbaro A; Cestari T; Tridente G; Accolla RS
    Immunogenetics; 1994; 39(1):8-14. PubMed ID: 7693585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-mediated transfer of major histocompatibility class II I-Ab and I-Abm12 genes into B lymphoma cells: molecular and functional analysis of introduced antigens.
    Ben-Nun A; Choi E; McIntyre KR; Leeman SA; McKean DJ; Seidman JG; Glimcher LH
    J Immunol; 1985 Aug; 135(2):1456-64. PubMed ID: 3925010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upstream DNA sequences required for tissue-specific expression of the HLA-DR alpha gene.
    Sherman PA; Basta PV; Ting JP
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4254-8. PubMed ID: 3495805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of HLA-DR antigen in human class II mutant B-cell lines by double infection with retrovirus vectors.
    Yang Z; Korman AJ; Cooper J; Pious D; Accolla RS; Mulligan RC; Strominger JL
    Mol Cell Biol; 1987 Nov; 7(11):3923-8. PubMed ID: 2828920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
    Muczynski KA; Anderson SK; Pious D
    J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the AIR-1 locus on the activation of an enhancerless HLA-DQA1 promoter.
    Ombra MN; Del Pozzo G; Perfetto C; Maffei A; Guardiola J
    Immunogenetics; 1990; 31(5-6):368-76. PubMed ID: 2370082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of class II gene expression in a murine pre-B cell line.
    Polla BS; Poljak A; Geier S; Nathenson SG; Ohara J; Paul WE; Glimcher LH
    Fed Proc; 1986 Dec; 45(13):2995-9. PubMed ID: 3536599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
    Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
    J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
    Diedrichs M; Schendel DJ
    J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo modification of major histocompatibility complex class II DRA promoter occupancy mediated by the AIR-1 trans-activator.
    Rigaud G; Paiola F; Accolla RS
    Eur J Immunol; 1994 Oct; 24(10):2415-20. PubMed ID: 7925569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence-specific interactions of nuclear factors with conserved sequences of human class II major histocompatibility complex genes.
    Miwa K; Doyle C; Strominger JL
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4939-43. PubMed ID: 3037529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.